Literature DB >> 23064919

Risks of venous thromboembolism with various hormonal contraceptives.

G Michael Allan1, Sudha Koppula.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23064919      PMCID： PMC3470507     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  10 in total

1.  Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.

Authors:  Susan S Jick; James A Kaye; Stefan Russmann; Hershel Jick
Journal:  Contraception       Date:  2006-03-29       Impact factor: 3.375

Review 2.  Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?

Authors:  R Lawrenson; R Farmer
Journal:  Contraception       Date:  2000-08       Impact factor: 3.375

3.  SOGC clinical practice guidelines: Oral contraceptives and the risk of venous thromboembolism: an update: no. 252, December 2010.

Authors:  Robert Reid; Nicholas Leyland; Wendy Wolfman; Catherine Allaire; Alaa Awadalla; Carolyn Best; Sheila Dunn; Madeleine Lemyre; Violaine Marcoux; Chantal Menard; Frank Potestio; David Rittenberg; Sukhbir Singh; Vyta Senikas
Journal:  Int J Gynaecol Obstet       Date:  2011-03       Impact factor: 3.561

Review 4.  Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.

Authors:  William A Fisher; Amanda Black
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

5.  The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.

Authors:  Jürgen C Dinger; Lothar A J Heinemann; Dörthe Kühl-Habich
Journal:  Contraception       Date:  2007-02-23       Impact factor: 3.375

Review 6.  Limited knowledge on progestogen-only contraception and risk of venous thromboembolism.

Authors:  Annica Bergendal; Viveca Odlind; Ingemar Persson; Helle Kieler
Journal:  Acta Obstet Gynecol Scand       Date:  2009       Impact factor: 3.636

7.  Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.

Authors:  Susan S Jick; James A Kaye; Stefan Russmann; Hershel Jick
Journal:  Contraception       Date:  2006-01-26       Impact factor: 3.375

8.  Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.

Authors:  Øjvind Lidegaard; Lars Hougaard Nielsen; Charlotte Wessel Skovlund; Finn Egil Skjeldestad; Ellen Løkkegaard
Journal:  BMJ       Date:  2011-10-25

9.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13

10.  Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.

Authors:  Ojvind Lidegaard; Lars Hougaard Nielsen; Charlotte Wessel Skovlund; Ellen Løkkegaard
Journal:  BMJ       Date:  2012-05-10
  10 in total
  1 in total

1.  Is the use of contraceptives associated with periodontal diseases? A systematic review and meta-analyses.

Authors:  Micaele Maria Lopes Castro; Maria Karolina Martins Ferreira; Iasmin Encaua Essashika Prazeres; Paula Beatriz de Oliveira Nunes; Marcela Baraúna Magno; Cassiano Kuchenbecker Rösing; Lucianne Cople Maia; Rafael Rodrigues Lima
Journal:  BMC Womens Health       Date:  2021-02-01       Impact factor: 2.809
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.